These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7000141)

  • 1. Long-term photochemotherapy: histopathological and immunofluorescence observations in 243 patients.
    Gschnait F; Wolff K; Hönigsmann H; Stingl G; Brenner W; Jaschke E; Konrad K
    Br J Dermatol; 1980 Jul; 103(1):11-22. PubMed ID: 7000141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histologic, immunofluorescent, and antinuclear antibody findings in PUVA-treated patients.
    Levin DL; Roenigk HH; Caro WA; Lyons M
    J Am Acad Dermatol; 1982 Mar; 6(3):328-33. PubMed ID: 7040505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term safety of trioxsalen bath PUVA treatment: an 8-year follow-up of 149 psoriasis patients.
    Berne B; Fischer T; Michaëlsson G; Norén P
    Photodermatol; 1984 Feb; 1(1):18-22. PubMed ID: 6531278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PUVA treatment and skin cancer: A follow-up study.
    Lassus A; Reunala T; Idänpää-Heikkilä J; Juvakoski T; Salo O
    Acta Derm Venereol; 1981; 61(2):141-5. PubMed ID: 6165190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antinuclear antibodies during Puva therapy.
    Bjellerup M; Bruze M; Forsgren A; Krook G; Ljunggren B
    Acta Derm Venereol; 1979; 59(1):73-5. PubMed ID: 84474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of minimal phototoxic dose and skin type for determining initial UVA dose in oral liquid methoxsalen photochemotherapy for the treatment of psoriasis.
    Rafal ES; Hamilton TA; Gonzalez E
    J Invest Dermatol; 1991 Dec; 97(6):1048-52. PubMed ID: 1748814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
    Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
    J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid deposition after psoriasis therapy with psoralen and long-wave ultraviolet light.
    Greene I; Cox AJ
    Arch Dermatol; 1979 Oct; 115(10):1200-2. PubMed ID: 507862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinuclear antibodies appearing during PUVA therapy.
    Bruze M; Ljunggren B
    Acta Derm Venereol; 1985; 65(1):31-6. PubMed ID: 2578703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperpigmentation and hypopigmentation of the skin after long term PUVA therapy. Light and electron microscopic observations on three patients.
    Kanerva L; Niemi KM; Lassus A
    J Cutan Pathol; 1981 Jun; 8(3):199-213. PubMed ID: 7309935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of trioxsalen bath and oral methoxsalen PUVA in psoriasis.
    Turjanmaa K; Salo H; Reunala T
    Acta Derm Venereol; 1985; 65(1):86-8. PubMed ID: 2578716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal lymphocyte function following long-term PUVA therapy for psoriasis.
    Morison WL; Wimberly J; Parrish JA; Bloch KJ
    Br J Dermatol; 1983 Apr; 108(4):445-50. PubMed ID: 6838768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Unusual adverse effects of oral photochemotherapy (PUVA-therapy) in psoriasis].
    Hofmann C; Plewig G; Braun-Falco O
    Hautarzt; 1977 Nov; 28(11):583-8. PubMed ID: 599020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of skin cancer in Japanese psoriatic patients treated with either methoxsalen phototherapy, Goeckerman regimen, or both therapies. A 10-year follow-up study.
    Torinuki W; Tagami H
    J Am Acad Dermatol; 1988 Jun; 18(6):1278-81. PubMed ID: 3385042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinuclear antibodies and PUVA photochemotherapy.
    Kubba R; Steck WD; Clough JD
    Arch Dermatol; 1981 Aug; 117(8):474-7. PubMed ID: 6973321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal dystrophy. Occurrence after psoriasis therapy with psoralen and long-wave ultraviolet light.
    Cox AJ; Abel EA
    Arch Dermatol; 1979 May; 115(5):567-70. PubMed ID: 443831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinuclear antibodies and oral methoxsalen photochemotherapy (PUVA) for psoriasis.
    Stern RS; Morison WL; Thibodeau LA; Kleinerman RA; Parrish JA; Geer DE; Fitzpatrick TB
    Arch Dermatol; 1979 Nov; 115(11):1320-4. PubMed ID: 389166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal dystrophy and actinic keratoses in psoriasis patients following oral psoralen photochemotherapy (PUVA). Follow-up study.
    Abel EA; Cox AJ; Farber EM
    J Am Acad Dermatol; 1982 Sep; 7(3):333-40. PubMed ID: 7130492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple keratoacanthomas possibly induced by psoralens and ultraviolet A photochemotherapy.
    Sina B; Adrian RM
    J Am Acad Dermatol; 1983 Nov; 9(5):686-8. PubMed ID: 6643766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bullous pemphigoid induced by PUVA therapy. Is this the aetiology of the acral bullae produced during PUVA treatment?
    Robinson JK; Baughman RD; Provost TT
    Br J Dermatol; 1978 Dec; 99(6):709-13. PubMed ID: 367423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.